Clinical Trial Update: Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX) [Phase 2]

View source ↗

Summary

Phase 2 study assessing the efficacy, safety and tolerability of AIN457 in rheumatoid arthritis patients taking methotrexate. The results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• AIN457

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2015-07-30